alpha-aminopyridine has been researched along with Thrombopenia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, S; Bajaj, A; Bhundia, V; Branson, A; Brookes, C; Darlison, L; Dawson, AG; Fennell, DA; Gaba, A; Greystoke, A; Hutka, M; King, A; Mohammed, S; Morgan, B; Nusrat, N; Poile, C; Richards, C; Scotland, M; Thomas, A; Wells-Jordan, P | 1 |
| Dierickx, D; Neefs, J | 1 |
| Kapur, R | 1 |
| Al-Horani, RA; Clemons Bankston, P | 1 |
| Dong, M; Fan, Y; Feng, J; Hong, X; Huang, H; Ke, X; Li, W; Lu, X; Ning, Z; Qi, J; Shen, Z; Shi, Y; Yu, L; Zhang, W; Zhao, X; Zhou, D; Zhu, J | 1 |
| Bai, O; Cai, Z; Chen, X; Ding, K; Dong, M; Gao, Y; He, H; Hou, M; Huang, H; Huang, X; Jia, B; Jin, J; Jin, Z; Li, W; Li, X; Li, Z; Liang, R; Liu, L; Liu, P; Liu, Q; Liu, T; Luo, J; Luo, Y; Qiu, L; Shen, J; Shi, Y; Song, Y; Su, H; Su, L; Sun, X; Sun, Z; Tan, H; Tang, X; Wang, H; Wang, J; Wang, S; Wang, X; Wu, G; Wu, J; Xu, J; Xu, W; Yang, H; Yang, J; Yi, P; Zeng, Q; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhang, Z; Zhao, W; Zhou, D; Zhou, J | 1 |
| Ballard, JO; Carlin, B; Kinney, EL; Zelis, R | 1 |
| Ansell, J; Benotti, JR; McCue, J; Parrilla, N; Tiarks, C | 1 |
| Brandt, JT; Hermiller, J; Leier, CV; Miller, L; Unverferth, DV | 1 |
| Webb-Peploe, MM; Wilsmhurst, PT | 1 |
| Barrett, PA; Chong, B; Lvoff, R; Robinson, PJ | 1 |
| Andrews, V; Fishman, AP; Janicki, JS; Weber, KT; Wilson, JR | 1 |
| Hubenette, A; Lee, S; O'Connor, L; Rubin, SA; Swan, HJ; Tober, J | 1 |
| LeJemtel, T; Mancini, D; Sonnenblick, E | 1 |
| Tommaso, CL | 1 |
| Treadway, G | 1 |
| Bounhoure, JP; Calazel, J; Massabuau, P; Miquel, JP; Puel, J | 1 |
4 review(s) available for alpha-aminopyridine and Thrombopenia
| Article | Year |
|---|---|
Evaluating fostamatinib disodium as a treatment option for immune thrombocytopenia in adult patients.
Topics: Adult; Aminopyridines; Humans; Morpholines; Oxazines; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Thrombocytopenia | 2022 |
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations.
Topics: Aminopyridines; Animals; Cinnamates; Drug Development; Humans; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, Thrombopoietin; Small Molecule Libraries; Syk Kinase; Thiazoles; Thiophenes; Thrombocytopenia | 2019 |
Intravenous use of amrinone for the treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Diseases; Heart Failure; Humans; Injections, Intravenous; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Thrombocytopenia; Vasodilator Agents | 1985 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors | 1986 |
4 trial(s) available for alpha-aminopyridine and Thrombopenia
| Article | Year |
|---|---|
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Topics: Alanine Transaminase; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Diarrhea; Hemoptysis; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Pulmonary Embolism; Respiratory Tract Infections; Sepsis; Thrombocytopenia; Vomiting | 2022 |
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult | 2015 |
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug Interactions; Gastrointestinal Diseases; Heart Failure; Humans; Hypotension; Thrombocytopenia | 1985 |
[Effects of amrinone administered orally and by injection in heart failure].
Topics: Administration, Oral; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Injections, Intravenous; Middle Aged; Thrombocytopenia | 1985 |
10 other study(ies) available for alpha-aminopyridine and Thrombopenia
| Article | Year |
|---|---|
Fine-tuning the treatment toolbox of immune thrombocytopenia: fostamatinib as a second-line therapy.
Topics: Aminopyridines; Humans; Morpholines; Oxazines; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Thrombocytopenia | 2020 |
Fostamatinib (Tavalisse) for ITP.
Topics: Aminopyridines; Drug Interactions; Humans; Morpholines; Oxazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Thrombocytopenia | 2019 |
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzamides; China; Disease-Free Survival; Fatigue; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2017 |
Amrinone-mediated thrombocytopenia.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Platelet Count; Thrombocytopenia | 1983 |
Amrinone-induced thrombocytopenia.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Platelets; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Immunoglobulin G; Indium; Male; Middle Aged; Platelet Count; Prospective Studies; Radioisotopes; Thrombocytopenia | 1984 |
Effect of oral amrinone on platelet function and survival.
Topics: Administration, Oral; Adult; Aminopyridines; Amrinone; Blood Platelets; Cardiotonic Agents; Cell Survival; Humans; Middle Aged; Thrombocytopenia | 1984 |
Side effects of amrinone therapy.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Female; Heart Failure; Humans; Hypotension; Infusions, Parenteral; Male; Middle Aged; Thrombocytopenia | 1983 |
Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Thrombocytopenia | 1981 |
Amrinone and exercise performance in patients with chronic heart failure.
Topics: Aminopyridines; Amrinone; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Thrombocytopenia | 1981 |
Thrombocytopenia and fever in a patient taking amrinone.
Topics: Aminopyridines; Cardiotonic Agents; Fever; Heart Failure; Humans; Male; Middle Aged; Thrombocytopenia | 1979 |